CLOV Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Clover Health Investments Corp (CLOV) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company has shown strong revenue growth, improving financial performance, and positive future projections. Despite some technical indicators being mixed, the overall sentiment, financial trends, and growth potential make this a suitable investment for long-term gains.
The MACD is positive and expanding, indicating bullish momentum. However, the moving averages are bearish (SMA_200 > SMA_20 > SMA_5), suggesting a potential downtrend in the short term. RSI is neutral at 63.874, and the price is trading near the pivot level of 2.053, with resistance at 2.141 and support at 1.965.
Clover Health reported adjusted EBITDA profitability in 2025 and expects GAAP net income profitability in
Revenue growth of 44.7% YoY in Q4 2025 and projections for 2026 revenue exceeding consensus estimates.
Medicare Advantage membership growth projections for
Strong YoY financial improvements in revenue, net income, and EPS.
The stock's moving averages indicate a bearish trend.
Post-market price drop of -2.54% after a regular market gain of 2.87%, showing some volatility.
In Q3 2025, revenue increased by 50.05% YoY to $496.65 million. Net income improved significantly by 166.27% YoY, though still negative at -$24.38 million. EPS improved by 150% YoY to -0.05. Gross margin remained stable at 100%. Q4 2025 revenue grew 44.7% YoY to $487.7 million, with strong growth projections for 2026.
Analyst sentiment is positive, with strong revenue growth and profitability projections for 2026. No recent changes in price targets or ratings were mentioned.
